Inhibiting the HIF2 protein was found to promote repair processes in a mouse model of lung injury, and may be a strategy for ...

Fatty acid synthase, the enzyme responsible for fatty acid production in cells, may be a therapeutic target for IPF, a mouse ...

As columnist Charlene Marshall looks ahead to 2025, she shares some of her New Year's wishes for fellow pulmonary fibrosis patients.

Columnist Sam Kirton believes in keeping new year's resolutions that help him manage his idiopathic pulmonary fibrosis.

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

The holidays have arrived, which reminds of those passenger-side mirrors that read, “Objects in mirror are closer than they appear.” It wasn’t too long ago that the holidays seemed far away, yet here ...

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

The investigational therapy LYT-100 (deupirfenidone) significantly slowed lung function decline in people with idiopathic pulmonary fibrosis (IPF), outperforming the standard of care therapy Esbriet.